Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Bone Marrow Transplantation

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 61 articles:
HTML format
Text format



Single Articles


    November 2011
  1. SAVVA-BORDALO J , Pinho Vaz C, Sousa M, Branca R, et al
    Clinical effectiveness of hyperbaric oxygen therapy for BK-virus-associated hemorrhagic cystitis after allogeneic bone marrow transplantation.
    Bone Marrow Transplant. 2011 Nov 14. doi: 10.1038/bmt.2011.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  2. INAMOTO Y , Yannucci J, Storb RF, Flowers ME, et al
    Recurrence of beta-thalassemia major more than 20 years after HLA-identical sibling BMT treated successfully with donor lymphocyte infusion.
    Bone Marrow Transplant. 2011;46:1037-8.
    PubMed     Text format     Related articles   



  3. HUANG M , Bayerl M, Lucas K
    An instructive case of hypercalcemia preceding relapse of AML following allogeneic BMT.
    Bone Marrow Transplant. 2011;46:1028-9.
    PubMed     Text format     Related articles   



    June 2011
  4. HEPGUR M , Ahluwalia MS, Anne N, Thomas J, et al
    Medical management of pneumatosis intestinalis in patients undergoing allogeneic blood and marrow transplantation.
    Bone Marrow Transplant. 2011;46:876-9.
    PubMed     Text format     Related articles    Abstract available



  5. SHARMA S , Yang S, Rochester R, Britton L, et al
    Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMT.
    Bone Marrow Transplant. 2011;46:813-9.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  6. ALFRED A , Vora AJ
    What is the minimum level of donor chimerism necessary to sustain transfusion independence in thalassaemia?
    Bone Marrow Transplant. 2011;46:769-70.
    PubMed     Text format     Related articles   



  7. ARBER C , Halter J, Stern M, Rovo A, et al
    Graft source determines human hematopoietic progenitor distribution pattern within the CD34(+) compartment.
    Bone Marrow Transplant. 2011;46:650-8.
    PubMed     Text format     Related articles    Abstract available



  8. SANCHEZ-ORTEGA I , Patino B, Arnan M, Peralta T, et al
    Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation.
    Bone Marrow Transplant. 2011;46:733-9.
    PubMed     Text format     Related articles    Abstract available



    April 2011

  9. Abstracts of EBMT (European Group for Blood and Marrow Transplantation) 2011. April 3-6, 2011. Paris, France.
    Bone Marrow Transplant. 2011;46 Suppl 1:S1-477.
    PubMed     Text format     Related articles   



  10. HILL-KAYSER CE , Plastaras JP, Tochner Z, Glatstein E, et al
    TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions.
    Bone Marrow Transplant. 2011;46:475-84.
    PubMed     Text format     Related articles    Abstract available



  11. OWAIDAH TM , Maghrabi K, Elkarouri MA, Al Mohareeb F, et al
    Successful treatment of a case of catastrophic antiphospholipid syndrome with autologous BMT: case report and review of literature.
    Bone Marrow Transplant. 2011;46:597-600.
    PubMed     Text format     Related articles   



    March 2011
  12. SHIGEMATSU H , Andou A, Matsuo K, Satoh T, et al
    Thoracoscopic surgery using local and epidural anesthesia for intractable pneumothorax after BMT.
    Bone Marrow Transplant. 2011;46:472-3.
    PubMed     Text format     Related articles   



  13. FREWER LJ , Coles D, van der Lans IA, Schroeder D, et al
    Impact of the European clinical trials directive on prospective academic clinical trials associated with BMT.
    Bone Marrow Transplant. 2011;46:443-7.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  14. ONODERA R , Teramukai S, Tanaka S, Kojima S, et al
    Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis.
    Bone Marrow Transplant. 2011;46:278-84.
    PubMed     Text format     Related articles    Abstract available



  15. TAKAMI A , Espinoza JL, Onizuka M, Ishiyama K, et al
    A single-nucleotide polymorphism of the Fcgamma receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignancies.
    Bone Marrow Transplant. 2011;46:238-43.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  16. UBERTI JP , Agovi MA, Tarima S, Haagenson M, et al
    Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia.
    Bone Marrow Transplant. 2011;46:34-43.
    PubMed     Text format     Related articles   



  17. DIETZ AC , Orchard PJ, Baker KS, Giller RH, et al
    Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.
    Bone Marrow Transplant. 2011;46:98-104.
    PubMed     Text format     Related articles   



  18. MCPHERSON ME , Hutcherson D, Olson E, Haight AE, et al
    Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease.
    Bone Marrow Transplant. 2011;46:27-33.
    PubMed     Text format     Related articles   



  19. OKAMURA A , Shimoyama M, Ishii S, Wakahashi K, et al
    Delayed neutrophil engraftment in cord blood transplantation with intensive administration of mycophenolate mofetil for GVHD prophylaxis.
    Bone Marrow Transplant. 2011;46:148-9.
    PubMed     Text format     Related articles   



  20. VERDEGUER A , de Heredia CD, Gonzalez M, Martinez AM, et al
    Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience.
    Bone Marrow Transplant. 2011;46:119-24.
    PubMed     Text format     Related articles   



    November 2010
  21. CUVELIER GD , Kariminia A, Fujii H, Aslanian S, et al
    Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031.
    Bone Marrow Transplant. 2010;45:1653-7.
    PubMed     Text format     Related articles    Abstract available



  22. RIPALDI M , Parasole R, De Simone G, D'Amico MR, et al
    Palonosetron to prevent nausea and vomiting in children undergoing BMT: efficacy and safety.
    Bone Marrow Transplant. 2010;45:1663-4.
    PubMed     Text format     Related articles   



    October 2010
  23. YABE M , Shimizu T, Morimoto T, Koike T, et al
    Alternative donor marrow transplantation in children with aplastic anemia using low-dose irradiation and fludarabine-based conditioning.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles   



  24. PALLUA S , Giesinger J, Oberguggenberger A, Kemmler G, et al
    Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation.
    Bone Marrow Transplant. 2010;45:1534-9.
    PubMed     Text format     Related articles    Abstract available



  25. GODOI DF , Cardoso CR, Ferraz DB, Provinciatto PR, et al
    Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease.
    Bone Marrow Transplant. 2010;45:1562-71.
    PubMed     Text format     Related articles    Abstract available



  26. THIANT S , Yakoub-Agha I, Magro L, Trauet J, et al
    Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse.
    Bone Marrow Transplant. 2010;45:1546-52.
    PubMed     Text format     Related articles    Abstract available



  27. MIURA T , Izawa A, Kumazaki S, Ishii E, et al
    Acute myocardial infarction in a 16-year-old girl with chronic GVHD.
    Bone Marrow Transplant. 2010;45:1576-7.
    PubMed     Text format     Related articles   



    September 2010
  28. YABE M , Morimoto T, Shimizu T, Koike T, et al
    Therapy-related myelodysplastic syndrome of recipient origin in a juvenile myelomonocytic leukemia patient 17 years after allogeneic BMT.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles   



  29. BECK JC , Cao Q, Trotz B, Smith AR, et al
    Allogeneic hematopoietic cell transplantation outcomes for children with B-precursor acute lymphoblastic leukemia and early or late BM relapse.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available



  30. DEZERN AE , Luznik L, Fuchs EJ, Jones RJ, et al
    Post-transplantation cyclophosphamide for GVHD prophylaxis in severe aplastic anemia.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles   



  31. ROOS-WEIL D , Nguyen S, Uzunov M, Bories D, et al
    Therapy-related myelodysplastic syndrome after allogeneic BMT: successful treatment by donor lymphocyte infusions.
    Bone Marrow Transplant. 2010;45:1471-3.
    PubMed     Text format     Related articles   



  32. SCRUCCA L , Santucci A, Aversa F
    Regression modeling of competing risk using R: an in depth guide for clinicians.
    Bone Marrow Transplant. 2010;45:1388-95.
    PubMed     Text format     Related articles    Abstract available



  33. IGNATOV AP , Eisenberg MS, Turek PJ
    Paternity after directed collection of testicular sperm for in vitro fertilization after BMT for hematological malignancies.
    Bone Marrow Transplant. 2010;45:1474-6.
    PubMed     Text format     Related articles   



    August 2010
  34. WESTEKEMPER H , Meller S, Citak S, Schulte C, et al
    Differential chemokine expression in chronic GVHD of the conjunctiva.
    Bone Marrow Transplant. 2010;45:1340-6.
    PubMed     Text format     Related articles    Abstract available



  35. ILARI I , De Ioris MA, Milano GM, Pessolano R, et al
    Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesu Children's Hospital.
    Bone Marrow Transplant. 2010;45:1274-80.
    PubMed     Text format     Related articles    Abstract available



  36. CHEN Y , Liu K, Xu L, Chen H, et al
    HLA-mismatched hematopoietic SCT without in vitro T-cell depletion for myelodysplastic syndrome.
    Bone Marrow Transplant. 2010;45:1333-9.
    PubMed     Text format     Related articles    Abstract available



  37. VAN WALRAVEN SM , Nicoloso-de Faveri G, Axdorph-Nygell UA, Douglas KW, et al
    Family donor care management: principles and recommendations.
    Bone Marrow Transplant. 2010;45:1269-73.
    PubMed     Text format     Related articles    Abstract available



  38. KANDA J , Ichinohe T, Saito T, Yamashita K, et al
    Impact of discontinuing fluoroquinolone prophylaxis on early mortality after allogeneic marrow or peripheral blood SCT with myeloablative conditioning.
    Bone Marrow Transplant. 2010;45:1369-71.
    PubMed     Text format     Related articles   



    July 2010
  39. MEYERS G , Maziarz RT
    Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available



  40. PAULSON K , Lambert P, Bredeson C, Demers A, et al
    Does location matter? Rural vs urban outcomes after blood and marrow transplantation in a population-based Canadian cohort.
    Bone Marrow Transplant. 2010;45:1167-73.
    PubMed     Text format     Related articles    Abstract available



  41. SOSTAK P , Padovan CS, Eigenbrod S, Roeber S, et al
    Cerebral angiitis in four patients with chronic GVHD.
    Bone Marrow Transplant. 2010;45:1181-8.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  42. BOCHTLER W , Maiers M, Bakker JN, Oudshoorn M, et al
    World Marrow Donor Association framework for the implementation of HLA matching programs in hematopoietic stem cell donor registries and cord blood banks.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available



  43. CHAPLOW R , Palmer B, Heyderman R, Moppett J, et al
    Stenotrophomonas maltophilia bacteraemia in 40 haematology patients: risk factors, therapy and outcome.
    Bone Marrow Transplant. 2010;45:1109-10.
    PubMed     Text format     Related articles   



  44. SHIMA C , Adachi Y, Shi M, Imai Y, et al
    The combination method using magnetic beads and a magnet helps sustain the number of donor BM cells after intra-BM injection, resulting in rapid hematopoietic recovery.
    Bone Marrow Transplant. 2010;45:993-9.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  45. LEMOLI RM , D'Addio A, Marotta G, Pezzullo L, et al
    BU/melphalan and auto-SCT in AML patients in first CR: a 'Gruppo Italiano Trapianto di Midollo Osseo (GITMO)' retrospective study.
    Bone Marrow Transplant. 2010;45:640-6.
    PubMed     Text format     Related articles    Abstract available



  46. MEGURO A , Ozaki K, Oh I, Hatanaka K, et al
    IL-21 is critical for GVHD in a mouse model.
    Bone Marrow Transplant. 2010;45:723-9.
    PubMed     Text format     Related articles    Abstract available



    March 2010

  47. Abstracts of EBMT (European Group for Blood and Bone Marrow Transplantation) 2010. March 21-14, 2010. Vienna, Austria.
    Bone Marrow Transplant. 2010;45 Suppl 2:S1-427.
    PubMed     Text format     Related articles   



  48. STUDTS JL , Ruberg JL, McGuffin SA, Roetzer LM, et al
    Decisions to register for the National Marrow Donor Program: rational vs emotional appeals.
    Bone Marrow Transplant. 2010;45:422-8.
    PubMed     Text format     Related articles    Abstract available



  49. KEEVER-TAYLOR CA , Wagner JE, Kernan NA, Small TN, et al
    Comparison of immune recovery in recipients of unmanipulated vs T-cell-depleted grafts from unrelated donors in a multicenter randomized phase II-III trial (T-cell depletion trial).
    Bone Marrow Transplant. 2010;45:587-9.
    PubMed     Text format     Related articles   



    February 2010
  50. LJUNGMAN P , Bregni M, Brune M, Cornelissen J, et al
    Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.
    Bone Marrow Transplant. 2010;45:219-34.
    PubMed     Text format     Related articles    Abstract available



  51. CUNDERLIKOVA B , Vasovic V, Sieber F, Furre T, et al
    Hexaminolevulinate-mediated photodynamic purging of leukemia cells from BM.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available



  52. YAGASAKI H , Takahashi Y, Hama A, Kudo K, et al
    Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available



    January 2010
  53. CHO BS , Eom KS, Kim YJ, Kim HJ, et al
    HLA-matched sibling transplantation with BM and CD34(+)-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available



  54. CLARE S , Mank A, Stone R, Davies M, et al
    Management of related donor care: a European survey.
    Bone Marrow Transplant. 2010;45:97-101.
    PubMed     Text format     Related articles    Abstract available



  55. VOSSEN JM , Donker AE, Heemskerk MB, Lie JL, et al
    Unrelated donor marrow transplantation in children: transplant policy and outcome in Leiden Paediatrics SCT-Centre.
    Bone Marrow Transplant. 2010;45:87-95.
    PubMed     Text format     Related articles    Abstract available



  56. STOTLER C , Bolwell B, Sobecks R, Dean R, et al
    Are backup BM harvests worthwhile in unrelated donor allogeneic transplants?
    Bone Marrow Transplant. 2010;45:49-52.
    PubMed     Text format     Related articles    Abstract available



    December 2009
  57. KANDA Y , Yamashita T, Mori T, Ito T, et al
    A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available



    November 2009
  58. KOHLI R , Xu W, Brandwein J, Minden MD, et al
    Long-term outcomes in adult patients below the age of 55 years with acute lymphoblastic leukemia treated with chemotherapy or allogeneic BM transplant in first CR.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles   



  59. XU LP , Liu KY, Liu DH, Chen H, et al
    The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched/haploidentical transplantation: a comparative analysis.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available



    October 2009
  60. XU S , Xu X, Guo Y, Gao W, et al
    Inflammatory responses after intracoronary mononuclear BM cell therapy in swine.
    Bone Marrow Transplant. 2009;44:427-31.
    PubMed     Text format     Related articles    Abstract available



    August 2009
  61. HAN TH , Tang Y, Park YH, Maynard J, et al
    Vector prime protein boost vaccination in the setting of myeloablative-induced lymphopenia suppresses growth of leukemia and solid tumors.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: